Clinical Trial Update: Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating rifampin for CYP24A1-related hypercalcemia and hypercalciuria in pediatric patients, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercalcemia Idiopathic of Infancy
• Hypercalciuria
• Idiopathic Infantile Hypercalcemia

Drugs mentioned

• RIFAMPIN (RIFAMPIN)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Idiopathic Infantile Hypercalcaemia - Severe Form, Genetic Disease | Phase 2 | Status: RECRUITING